Rhonda F. Rhyne

Ms. Rhyne has more than 25 years of experience in health care with both public and private industry companies, as well as experience as a clinical pharmacist. She is President and CEO of Prevencio Medical. She was previously President of CardioDynamics, a publicly-traded medical device company sold to SonoSite Inc. in 2009. Prior to CardioDynamics, Ms. Rhyne held positions of President & CEO, VP of Sales and Marketing, and Board Director at Culture Technology, Inc., a privately-held biotechnology company, as well as positions at GE Health Care and Cardiac Science. She also serves on the Board of Directors and Audit Committee for La Jolla Institute of Allergy and Immunology, Deeds from the Heart and Washington State University College of Pharmacy Dean’s Advisory Council. She was selected by Ernst & Young as Entrepreneur of the Year in Medical Devices.